The goal is to highlight basic and translational research progress at GCC and to foster internal collaborations to empower Cancer research. The keynote speaker will be Raymond N. DuBois, MD, PhD, Director of the Hollings Cancer Center, The Medical University of South Carolina.
The event will include plenary sessions, trainee elevator talks (chosen from abstracts), and lunchtime networking and poster presentations.
Friday, June 28, 2024
Augusta Marriott at the Convention Center
Oglethorpe Ballroom (Second Floor)
2 10th Street
Augusta, GA 30901
Registration & Abstract Deadline is June 6, 2024 at 11:59 p.m.
Registration Only Registration & Abstract Submission Award Nominations
Registration & Breakfast
Welcome
David Hess, MD, EVP, Medical Affairs and Dean, Medical College of Georgia
Keynote Lecture
Raymond N. DuBois, MD, PhD, Director of MUSC Hollings Cancer Center
Path Towards NCI Designation
Jorge Cortes, MD, Director, Georgia Cancer Center
Break
Molecular Oncology & Biomarkers Research Program
10:30-10:45 am
Molecular Oncology & Biomarker Research Program, Present & Future
Nahid Mivechi, PhD, Professor of Radiation Oncology & Program Leader for Molecular
Oncology & Biomarker Research Program
10:50-11:05 am
Kidney, Bladder & Prostate Research Program at Georgia Cancer Center
Balakrishna Lokeshwar, PhD, Professor, Georgia Cancer Center
11:10-11:25 am
Blockade of TREM1 signaling as a novel therapeutic approach for cancer treatment
Anatolij Horuzsko, MD, PhD, Professor of Medicine, Biochemistry and Molecular Biology
State of the Research in Georgia Cancer Center
Balveen Kaur, PhD, Professor of Pathology and Associate Director, Georgia Cancer Center
Lunch & Poster Presentations
Cancer Immunology Research Program
2:00 – 2:15 pm
Cancer Immunology Program Overview
Catherine “Lynn” Hedrick, PhD, Professor of Medicine, Head of Cancer Immunology, Inflammation,
& Tolerance (CIIT) Division of GCC
2:15-2:30 pm
The CD73-ADO immune checkpoint during tumor progression and therapy
Yan Cui, PhD, Professor, Biochemistry & Molecular Biology
2:30-2:45 pm
Targeting the RAS-MAPK signaling pathway to unleash antitumor immunity
Gang Zhou, PhD, Professor of Medicine, Biochemistry & Molecular Biology
2:45-3:00
CAR T cell affinity: Moderate is better
Yukai He, MD, PhD, Professor of Medicine, Biochemistry & Molecular Biology
State of Clinical Research
Vamsi Kota, MD, Professor of Medicine, Director of Bone Marrow & Stem Cell Transplant
Program
Outstanding Awardee Talks (Two 20-minute talks)
Posters & Art of Cancer Science awardee announcements
Raymond N. DuBois, M.D., Ph.D., is the director of MUSC Hollings Cancer Center and the associate provost of cancer programs at MUSC. As a physician-scientist, DuBois is passionate about cancer research and patient-centered care. He drives the strategy to strengthen and grow Hollings’ impact on cancer care in South Carolina. An international leader in the cancer community, DuBois has more than 30 years of research experience and over 20 years of concurrent leadership experience, including senior roles at MD Anderson Cancer Center and Vanderbilt-Ingram Cancer Center. He was elected to the National Academy of Medicine in 2019, which places him in the company of an elite group of internationally renowned scientists and doctors.
The Georgia Cancer Center (GCC) at Augusta University is pleased to release a call for Abstracts for poster presentations at the 2024 Annual GCC Cancer Center Retreat. Trainees are especially encouraged to submit research abstracts for poster presentations relevant to cancer prevention, diagnosis, discovery, and treatment in order to compete for awards.
Poster/Abstract Presentation Awards will be given to top-scoring abstracts for cancer-related projects in the following categories:
Submission Form and Abstract must be submitted as a single pdf using the link below:
Registration & Abstract Submission
Abstract Submission Deadline is June 6, 2024
(please download and use application template)
Submission Form
Abstract (all documents should be provided in standard NIH format, 0.5” margins, Arial 12 font)